In the article, “Health providers pressured by insurance, drug costs” by Tom DiChristopher, DiChristopher discusses how the financial pressures from high drugs costs, and negotiations with insurance companies effect the health care provider. This is a point of view that is not often discussed. The typical discussion that people have is about how the cost directly effects the patients. The article states that health care providers are trying to deliver high quality care at a much lower price. Health care providers are struggling with how to do this.
The biggest issue I have with health care providers trying to limit their care by how much things cost is I worry that patients will not be receiving as high quality care as they may have in the past. I believe it is not a health care providers responsibility to worry about how much things cost while they are trying to save someones life. Health care providers are trained to save lives not save money. I believe the real problem is why health care cost so much in the first place. In the article it discusses how one of the biggest problems is how much medication costs. I believe this is the core of the issue. If the pharmaceutical companies are not forced to lower their prices, health care professionals may be forced to treat patients in ways that are not as efficient. In the article it is argued that the price is justified because of the amount of research that goes into the product and they believe if they produce a life saving product they should receive a profit. I agree that there is a substantial amount of research that goes into these products, and that the scientist and pharmaceutical companies should be rewarded, however, if the product is too expensive for the patients who need it, the purpose has been defeated. Health care should put their patients first not their business.
At the end of the article Noseworthy said, “We’ve basically defunded the NIH over the last 11 years, and that’s a problem if you’re going to be the leading developer of new treatments in medicine. Our position could fall if that doesn’t turn around.” Because the United States is a leading developer in new treatments in medicine there is a lot of expectations and pressure put on us. Trying to solve the problem of high health care costs by defunded research is not the answer. They are taking the money from the wrong place. The real issue is with the pharmaceutical companies, and how the charge master prices are developed. If something doesn’t change, and health care providers are expected to deal with the business side of health care while treating patients, or high quality health care system will diminish.
Article: http://www.cnbc.com/2015/10/30/health-providers-pressured-by-insurance-drug-costs.html